Asthma - Pipeline Review, H1 2014

Global Markets Direct
April 30, 2014
686 Pages - GMD12030
$2,500.00

Summary

Global Markets Direct’s, ‘Asthma - Pipeline Review, H1 2014’, provides an overview of the Asthma’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Asthma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Asthma and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Asthma
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Asthma and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Asthma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Asthma pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Asthma
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Asthma pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

'

Table of Contents
Table of Contents 2
Introduction 8
Asthma Overview 9
Therapeutics Development 10
Asthma - Therapeutics under Development by Companies 12
Asthma - Therapeutics under Investigation by Universities/Institutes 23
Asthma - Pipeline Products Glance 26
Asthma - Products under Development by Companies 30
Asthma - Products under Investigation by Universities/Institutes 46
Asthma - Companies Involved in Therapeutics Development 47
Asthma - Therapeutics Assessment 173
Drug Profiles 195
Asthma - Recent Pipeline Updates 535
Asthma - Dormant Projects 622
Asthma - Discontinued Products 643
Asthma - Product Development Milestones 648
Appendix 657

List of Tables
Number of Products under Development for Asthma, H1 2014 38
Number of Products under Development for Asthma - Comparative Analysis, H1 2014 39
Number of Products under Development by Companies, H1 2014 41
Number of Products under Development by Companies, H1 2014 (Contd..1) 42
Number of Products under Development by Companies, H1 2014 (Contd..2) 43
Number of Products under Development by Companies, H1 2014 (Contd..3) 44
Number of Products under Development by Companies, H1 2014 (Contd..4) 45
Number of Products under Development by Companies, H1 2014 (Contd..5) 46
Number of Products under Development by Companies, H1 2014 (Contd..6) 47
Number of Products under Development by Companies, H1 2014 (Contd..7) 48
Number of Products under Development by Companies, H1 2014 (Contd..8) 49
Number of Products under Development by Companies, H1 2014 (Contd..9) 50
Number of Products under Investigation by Universities/Institutes, H1 2014 52
Number of Products under Investigation by Universities/Institutes, H1 2014 (Contd..1) 53
Comparative Analysis by Late Stage Development, H1 2014 54
Comparative Analysis by Clinical Stage Development, H1 2014 55
Comparative Analysis by Early Stage Development, H1 2014 56
Comparative Analysis by Unknown Stage Development, H1 2014 57
Products under Development by Companies, H1 2014 58
Products under Development by Companies, H1 2014 (Contd..1) 59
Products under Development by Companies, H1 2014 (Contd..2) 60
Products under Development by Companies, H1 2014 (Contd..3) 61
Products under Development by Companies, H1 2014 (Contd..4) 62
Products under Development by Companies, H1 2014 (Contd..5) 63
Products under Development by Companies, H1 2014 (Contd..6) 64
Products under Development by Companies, H1 2014 (Contd..7) 65
Products under Development by Companies, H1 2014 (Contd..8) 66
Products under Development by Companies, H1 2014 (Contd..9) 67
Products under Development by Companies, H1 2014 (Contd..10) 68
Products under Development by Companies, H1 2014 (Contd..11) 69
Products under Development by Companies, H1 2014 (Contd..12) 70
Products under Development by Companies, H1 2014 (Contd..13) 71
Products under Development by Companies, H1 2014 (Contd..14) 72
Products under Development by Companies, H1 2014 (Contd..15) 73
Products under Investigation by Universities/Institutes, H1 2014 74
Asthma - Pipeline by Alcon, Inc., H1 2014 75
Asthma - Pipeline by Johnson & Johnson, H1 2014 76
Asthma - Pipeline by Boehringer Ingelheim GmbH, H1 2014 77
Asthma - Pipeline by F. Hoffmann-La Roche Ltd., H1 2014 78
Asthma - Pipeline by Kyowa Hakko Kirin Co., Ltd., H1 2014 79
Asthma - Pipeline by Amgen Inc., H1 2014 80
Asthma - Pipeline by AstraZeneca PLC, H1 2014 81
Asthma - Pipeline by GlaxoSmithKline plc, H1 2014 82
Asthma - Pipeline by Genentech, Inc., H1 2014 83
Asthma - Pipeline by Biotec Pharmacon ASA, H1 2014 84
Asthma - Pipeline by MedImmune, LLC, H1 2014 85
Asthma - Pipeline by Daiichi Sankyo Company, Limited, H1 2014 86
Asthma - Pipeline by Merck & Co., Inc., H1 2014 87
Asthma - Pipeline by Nissan Chemical Industries, Ltd., H1 2014 88
Asthma - Pipeline by Dainippon Sumitomo Pharma Co., Ltd., H1 2014 89
Asthma - Pipeline by Takeda Pharmaceutical Company Limited, H1 2014 90
Asthma - Pipeline by SkyePharma PLC, H1 2014 91
Asthma - Pipeline by BioLineRx, Ltd., H1 2014 92
Asthma - Pipeline by Hanwha Chemical Corporation, H1 2014 93
Asthma - Pipeline by Novartis AG, H1 2014 94
Asthma - Pipeline by Activaero GmbH, H1 2014 95
Asthma - Pipeline by Actelion Ltd, H1 2014 96
Asthma - Pipeline by ASKA Pharmaceutical Co., Ltd., H1 2014 97
Asthma - Pipeline by Astellas Pharma Inc., H1 2014 98
Asthma - Pipeline by Chiesi Farmaceutici SpA, H1 2014 99
Asthma - Pipeline by Glenmark Pharmaceuticals Ltd., H1 2014 100
Asthma - Pipeline by Kissei Pharmaceutical Co., Ltd., H1 2014 101
Asthma - Pipeline by Laboratoires Pierre Fabre SA, H1 2014 102
Asthma - Pipeline by Mitsubishi Tanabe Pharma Corporation, H1 2014 103
Asthma - Pipeline by Ono Pharmaceutical Co., Ltd., H1 2014 104
Asthma - Pipeline by Orion Oyj, H1 2014 105
Asthma - Pipeline by Pfizer Inc., H1 2014 106
Asthma - Pipeline by SK Chemicals Co., Ltd., H1 2014 107
Asthma - Pipeline by Teva Pharmaceutical Industries Limited, H1 2014 108
Asthma - Pipeline by Zambon Company S.p.A., H1 2014 109
Asthma - Pipeline by Sun Pharmaceutical Industries Limited, H1 2014 110
Asthma - Pipeline by OPKO Health, Inc., H1 2014 111
Asthma - Pipeline by Antisense Therapeutics Limited, H1 2014 112
Asthma - Pipeline by Almirall, S.A., H1 2014 113
Asthma - Pipeline by Basilea Pharmaceutica AG, H1 2014 114
Asthma - Pipeline by Mesoblast Limited, H1 2014 115
Asthma - Pipeline by Orchid Chemicals & Pharmaceuticals Ltd, H1 2014 116
Asthma - Pipeline by Palatin Technologies, Inc., H1 2014 117
Asthma - Pipeline by Pharmaxis Limited, H1 2014 118
Asthma - Pipeline by CSL Limited, H1 2014 119
Asthma - Pipeline by Cytokinetics, Incorporated, H1 2014 120
Asthma - Pipeline by Yungjin Pharm Ind. Co., Ltd., H1 2014 121
Asthma - Pipeline by Yuhan Corporation, H1 2014 122
Asthma - Pipeline by WhanIn Pharmaceutical Co., Ltd., H1 2014 123
Asthma - Pipeline by Regeneron Pharmaceuticals, Inc., H1 2014 124
Asthma - Pipeline by NeoStem, Inc., H1 2014 125
Asthma - Pipeline by Array BioPharma Inc., H1 2014 126
Asthma - Pipeline by Dynavax Technologies Corporation, H1 2014 127
Asthma - Pipeline by Ahn-Gook Pharmaceutical Co., Ltd., H1 2014 128
Asthma - Pipeline by Neurim Pharmaceuticals Ltd, H1 2014 129
Asthma - Pipeline by Synairgen plc, H1 2014 130
Asthma - Pipeline by Orexo AB, H1 2014 131
Asthma - Pipeline by Verona Pharma Plc, H1 2014 132
Asthma - Pipeline by Morphotek, Inc., H1 2014 133
Asthma - Pipeline by Alba Therapeutics Corporation, H1 2014 134
Asthma - Pipeline by Immupharma Plc, H1 2014 135
Asthma - Pipeline by Farmacija d.o.o. Tuzla, H1 2014 136
Asthma - Pipeline by Pieris AG, H1 2014 137
Asthma - Pipeline by Respiratorius AB, H1 2014 138
Asthma - Pipeline by Hutchison MediPharma Limited, H1 2014 139
Asthma - Pipeline by Aquinox Pharmaceuticals Inc., H1 2014 140
Asthma - Pipeline by Proteologics Ltd., H1 2014 141
Asthma - Pipeline by AnaptysBio, Inc., H1 2014 142
Asthma - Pipeline by Circassia Ltd, H1 2014 143
Asthma - Pipeline by Nostrum Pharmaceuticals, LLC, H1 2014 144
Asthma - Pipeline by Promedior, Inc., H1 2014 145
Asthma - Pipeline by Oxagen Limited, H1 2014 146
Asthma - Pipeline by Pulmatrix, Inc., H1 2014 147
Asthma - Pipeline by Axikin Pharmaceuticals, Inc., H1 2014 148
Asthma - Pipeline by MSM Protein Technologies, Inc., H1 2014 149
Asthma - Pipeline by Hydra Biosciences, Inc., H1 2014 150
Asthma - Pipeline by Theraclone Sciences, Inc., H1 2014 151
Asthma - Pipeline by Polyphor Ltd., H1 2014 152
Asthma - Pipeline by Monosol Rx, LLC, H1 2014 153
Asthma - Pipeline by Omeros Corporation, H1 2014 154
Asthma - Pipeline by Xencor, Inc., H1 2014 155
Asthma - Pipeline by Cornerstone Therapeutics Inc., H1 2014 156
Asthma - Pipeline by Cellceutix Corporation, H1 2014 157
Asthma - Pipeline by Invion Limited, H1 2014 158
Asthma - Pipeline by AB Science, H1 2014 159
Asthma - Pipeline by Vitae Pharmaceuticals, Inc., H1 2014 160
Asthma - Pipeline by Adamis Pharmaceuticals Corporation, H1 2014 161
Asthma - Pipeline by Asmacure Ltee, H1 2014 162
Asthma - Pipeline by Protagonist Therapeutics Inc., H1 2014 163
Asthma - Pipeline by CalciMedica, Inc., H1 2014 164
Asthma - Pipeline by ISU ABXIS Co.,Ltd., H1 2014 165
Asthma - Pipeline by Receptos, Inc., H1 2014 166
Asthma - Pipeline by KAEL-GemVax Co., Ltd., H1 2014 167
Asthma - Pipeline by Afferent Pharmaceuticals, Inc., H1 2014 168
Asthma - Pipeline by iCeutica, Inc., H1 2014 169
Asthma - Pipeline by GlycoMar Limited, H1 2014 170
Asthma - Pipeline by Cognosci, Inc., H1 2014 171
Asthma - Pipeline by LegoChem Biosciences, Inc, H1 2014 172
Asthma - Pipeline by Trimel BioPharma SRL, H1 2014 173
Asthma - Pipeline by Fountain Biopharma Inc., H1 2014 174
Asthma - Pipeline by Clarassance, Inc., H1 2014 175
Asthma - Pipeline by Spring Bank Pharmaceuticals, Inc., H1 2014 176
Asthma - Pipeline by Apellis Pharmaceuticals, Inc., H1 2014 177
Asthma - Pipeline by Corridor Pharmaceuticals Inc., H1 2014 178
Asthma - Pipeline by Amakem NV, H1 2014 179
Asthma - Pipeline by Sunovion Pharmaceuticals Inc., H1 2014 180
Asthma - Pipeline by Neopharm Co., Ltd., H1 2014 181
Asthma - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H1 2014 182
Asthma - Pipeline by Griffin Discoveries BV, H1 2014 183
Asthma - Pipeline by PharmaLundensis AB, H1 2014 184
Asthma - Pipeline by High Point Pharmaceuticals, LLC, H1 2014 185
Asthma - Pipeline by Visionary Pharmaceuticals, Inc., H1 2014 186
Asthma - Pipeline by Qu Biologics Inc., H1 2014 187
Asthma - Pipeline by Incozen Therapeutics Pvt Ltd, H1 2014 188
Asthma - Pipeline by sterna biologicals Gmbh & Co KG, H1 2014 189
Asthma - Pipeline by Rhizen Pharmaceuticals SA, H1 2014 190
Asthma - Pipeline by ARA Healthcare Pvt. Ltd., H1 2014 191
Asthma - Pipeline by Panmira Pharmaceuticals, LLC., H1 2014 192
Asthma - Pipeline by ReveraGen BioPharma, Inc., H1 2014 193
Asthma - Pipeline by Dignity Sciences Ltd., H1 2014 194
Asthma - Pipeline by Agilvax, Inc., H1 2014 195
Asthma - Pipeline by Foresee Pharmaceuticals, LLC, H1 2014 196
Asthma - Pipeline by Ziarco Pharma Ltd, H1 2014 197
Asthma - Pipeline by Cellular Biomedicine Group, Inc., H1 2014 198
Asthma - Pipeline by vida therapeutics inc., H1 2014 199
Asthma - Pipeline by INOXIA Lifesciences GmbH, H1 2014 200
Assessment by Monotherapy Products, H1 2014 201
Assessment by Combination Products, H1 2014 202
Number of Products by Stage and Target, H1 2014 205
Number of Products by Stage and Mechanism of Action, H1 2014 212
Number of Products by Stage and Route of Administration, H1 2014 219
Number of Products by Stage and Molecule Type, H1 2014 222
Asthma Therapeutics - Recent Pipeline Updates, H1 2014 563
Asthma - Dormant Projects, H1 2014 650
Asthma - Dormant Projects (Contd..1), H1 2014 651
Asthma - Dormant Projects (Contd..2), H1 2014 652
Asthma - Dormant Projects (Contd..3), H1 2014 653
Asthma - Dormant Projects (Contd..4), H1 2014 654
Asthma - Dormant Projects (Contd..5), H1 2014 655
Asthma - Dormant Projects (Contd..6), H1 2014 656
Asthma - Dormant Projects (Contd..7), H1 2014 657
Asthma - Dormant Projects (Contd..8), H1 2014 658
Asthma - Dormant Projects (Contd..9), H1 2014 659
Asthma - Dormant Projects (Contd..10), H1 2014 660
Asthma - Dormant Projects (Contd..11), H1 2014 661
Asthma - Dormant Projects (Contd..12), H1 2014 662
Asthma - Dormant Projects (Contd..13), H1 2014 663
Asthma - Dormant Projects (Contd..14), H1 2014 664
Asthma - Dormant Projects (Contd..15), H1 2014 665
Asthma - Dormant Projects (Contd..16), H1 2014 666
Asthma - Dormant Projects (Contd..17), H1 2014 667
Asthma - Dormant Projects (Contd..18), H1 2014 668
Asthma - Dormant Projects (Contd..19), H1 2014 669
Asthma - Dormant Projects (Contd..20), H1 2014 670
Asthma - Discontinued Products, H1 2014 671
Asthma - Discontinued Products (Contd..1), H1 2014 672
Asthma - Discontinued Products (Contd..2), H1 2014 673
Asthma - Discontinued Products (Contd..3), H1 2014 674
Asthma - Discontinued Products (Contd..4), H1 2014 675

List of Figures
Number of Products under Development for Asthma, H1 2014 38
Number of Products under Development for Asthma - Comparative Analysis, H1 2014 39
Number of Products under Development by Companies, H1 2014 40
Number of Products under Investigation by Universities/Institutes, H1 2014 51
Comparative Analysis by Late Stage Development, H1 2014 54
Comparative Analysis by Clinical Stage Development, H1 2014 55
Comparative Analysis by Early Stage Products, H1 2014 56
Assessment by Monotherapy Products, H1 2014 201
Assessment by Combination Products, H1 2014 202
Number of Products by Top 10 Target, H1 2014 203
Number of Products by Stage and Top 10 Target, H1 2014 204
Number of Products by Top 10 Mechanism of Action, H1 2014 210
Number of Products by Stage and Top 10 Mechanism of Action, H1 2014 211
Number of Products by Top 10 Route of Administration, H1 2014 217
Number of Products by Stage and Top 10 Route of Administration, H1 2014 218
Number of Products by Top 10 Molecule Type, H1 2014 220
Number of Products by Stage and Top 10 Molecule Type, H1 2014 221

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Discount Codes

Request Discount Codes
for reports of interest to you.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax